Table 4 Sensitivity analysis at reduced AL cost and low-transmission for three malaria diagnostic strategies, Tigray, 2007
At reduced AL price | Low transmission season (15% SPR) | |||||
|---|---|---|---|---|---|---|
Comparison | Strategy | Strategies | ||||
Paracheck-BS | Parascreen-BS | Presumptive-BS | Paracheck-BS | Parascreen-BS | Presumptive-BS | |
Base case cost | 2704.49 | 3629.76 | 5017.20 | 2704.49 | 3629.76 | 5017.2 |
Total new cost | 2300.80 | 3264.20 | 3192.70 | 1926.05 | 2908.56 | 5017.20 |
Cost change within strategy | 403.69 | 364.56 | 1886.50 | 778.44 | 720.20 | 0 |
Cost change in (%) | (14.93) | (10.05) | (37.14) | (28.78) | (19.85) | 0 |
Correctly treated cases (n, %) | 580 (23.95) | 2143 (88.48) | 453 (18.7) | 315 (13.01) | 2253 (93.02) | 127 (5.24) |
ACER at reduced AL and SPR | 3.97 | 1.52 | 7.05 | 6.11 | 1.29 | 39.51 |
ACER Change from base case, % | (14.81) | (10.06) | (36.2) | (+31.1) | (23.67) | (+258) |
Cost difference b/n strategy | 0.00 | 963.40 | -71.50 | 0.00 | 982.51 | 2108.64 |
Effect difference b/n strategy | 0.00 | 1563.00 | -1690 | 0.00 | 1938 | -2124 |
ICER | - | 0.62 | dominated | - | 0.51 | dominated |